High-dose-rate interstitial brachytherapy as monotherapy in one fraction of 20.5 Gy for the treatment of localized prostate cancer: Toxicity and 6-year biochemical results

Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference

Mack Roach, Gerald E. Hanks, Howard D. Thames et al. · International Journal of Radiation Oncology*Biology*Physics · 2006 · 2.7K citations

Medicine, Radiation Oncology, Urology +14

Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer

Michael J. Zeléfsky, StevenA Leibel, PaulB Gaudin et al. · International Journal of Radiation Oncology*Biology*Physics · 1998 · 926 citations

Medicine, Oncology, Radiation Oncology +16

High-Dose-Rate Interstitial Brachytherapy as Monotherapy for Clinically Localized Prostate Cancer: Treatment Evolution and Mature Results

Nikolaos Zamboglou, Nikolaos Tselis, Dimos Baltas et al. · International Journal of Radiation Oncology*Biology*Physics · 2012 · 159 citations

Medicine, Radiation Oncology, Urology +10

Transperineal Injection of Hyaluronic Acid in Anterior Perirectal Fat to Decrease Rectal Toxicity From Radiation Delivered With Intensity Modulated Brachytherapy or EBRT for Prostate Cancer Patients

Pedro J. Prada, José M. Fernández, Alvaro A. Martinez et al. · International Journal of Radiation Oncology*Biology*Physics · 2007 · 157 citations

Medicine, Radiation Oncology, Surgery +17

Monotherapeutic High-Dose-Rate Brachytherapy for Prostate Cancer: Five-Year Results of an Extreme Hypofractionation Regimen With 54 Gy in Nine Fractions

Yasuo Yoshioka, Koji Konishi, Iori Sumida et al. · International Journal of Radiation Oncology*Biology*Physics · 2010 · 108 citations

Medicine, Oncology, Radiation Oncology +10